CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr | ₹116 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹149 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹100 Cr |
| Mar2021 | ₹116 Cr |
How is Long Term Provisions of CIPLA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹149 Cr | 15.03 | |
| Mar2024 | ₹129 Cr | 26.53 | |
| Mar2023 | ₹102 Cr | 1.94 | |
| Mar2022 | ₹100 Cr | -13.73 | |
| Mar2021 | ₹116 Cr | - | |
Compare Long Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,506.1 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
| MANKIND PHARMA | ₹85,050.2 Cr | -1.1% | -8.2% | -17.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.9% |
-7.2% |
-9.7% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses